Clinical trial
An Observational Follow up Study of a Randomised Parallel Group Phase IV Study to Evaluate the Duration of the Immune Response to Vaccine and Non-vaccine HPV Types in UK Adolescent Females Who Received Either Cervarix or Gardasil Human Papillomavirus (HPV) Vaccines
NCT02811068 is registered in ClinicalTrials.gov with Public Health England as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Observational Follow up Study of a Randomised Parallel Group Phase IV Study to Evaluate the Duration of the Immune Response to Vaccine and Non-vaccine HPV Types in UK Adolescent Females Who Received Either Cervarix or Gardasil Human Papillomavirus (HPV) Vaccines
- Lead sponsor
- Public Health England
- Phase
- Observational
- Overall status
- Completed
- Start date
- December 31, 2016
- Completion date
- December 31, 2017
- Enrollment
- 93 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
human papillomavirus virus